Leptin in autoimmune mechanisms of systemic rheumatic diseases
- 1 June 2018
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 423, 139-146
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritisArthritis Research & Therapy, 2013
- Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritisArthritis Research & Therapy, 2012
- Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritisAnnals of the Rheumatic Diseases, 2012
- Leptin Activates Human B Cells to Secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 Signaling PathwayJournal of Clinical Immunology, 2011
- An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell ResponsivenessImmunity, 2010
- Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 monthsArthritis Research & Therapy, 2010
- Role of Leptin in the Activation of Immune CellsMediators of Inflammation, 2010
- Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosisLupus, 2009
- A role for leptin in sustaining lymphopoiesis and myelopoiesisProceedings of the National Academy of Sciences, 2008
- No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006